<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-PGH2FH5Q</identifier><date>2017</date><relation>documents/doc/P/URN_NBN_SI_doc-PGH2FH5Q_001.pdf</relation><relation>documents/doc/P/URN_NBN_SI_doc-PGH2FH5Q_001.txt</relation><format format_type="extent">1 zv., 20 x 30 cm</format><identifier identifier_type="COBISSID_HOST">2780539</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-PGH2FH5Q</identifier><language>eng</language><publisher>Institute of Oncology Ljubljana</publisher><publisher>Slovenian Senologic Society</publisher><source>knjige</source><rights>InC</rights><subject language_type_id="slv">rak dojke</subject><subject language_type_id="slv">rak jajčnikov</subject><subject language_type_id="slv">zborniki</subject><title>2nd conference, 19th October 2017, Ljubljana</title><title>What's new in the management of Brca positive ovarian and breast cancer patients</title></Record>